Kevin H. Dang
Kevin H. Dang publishes mostly in Oncology, Radiology, Nuclear Medicine and Imaging and Immunology, on topics such as CAR-T cell therapy research, Monoclonal and Polyclonal Antibodies Research and Biosimilars and Bioanalytical Methods.
- World rank
- #1,807,608 of 7,710,434 ranked researchers
- Rank in United States
- #555,201 of 1,627,098
- Works
- 33
- Citations
- 765
- Citations per work
- 23.2
What does Kevin H. Dang research?
Kevin H. Dang's work is mostly in Medicine (50%), Immunology and Microbiology (14%), Biochemistry, Genetics and Molecular Biology (12%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences1649.9%
- Medicine1649.9%
- Life Sciences926.7%
- Everything else823.4%
- 1Oncology23% of their works
- 2Radiology, Nuclear Medicine and Imaging23% of their works
- 3Immunology14% of their works
- 4Molecular Biology7% of their works
- 5Physiology6% of their works
- 6Epidemiology3% of their works
Research topics
- CAR-T cell therapy research
- Monoclonal and Polyclonal Antibodies Research
- Biosimilars and Bioanalytical Methods
- Glycosylation and Glycoproteins Research
- Calcium signaling and nucleotide metabolism
- Immunotherapy and Immune Responses
- Radiopharmaceutical Chemistry and Applications
- Adenosine and Purinergic Signaling
Which keywords describe Kevin H. Dang's research?
The keywords of their largest research topics: Monoclonal Antibodies, Cancer Immunotherapy, Glycosylation, CAR T Cells, Chimeric Antigen Receptor, Fc Receptors, Therapeutic Antibodies and Biosimilars.
- Adenosine Receptors
- Radiopharmaceuticals
- Lysosomal Calcium Signaling
- Dendritic Cells
- Cancer
- Biosimilars
- Fc Receptors
- CAR T Cells
- Cancer Immunotherapy
- Monoclonal Antibodies
- Glycosylation
- Chimeric Antigen Receptor
- Therapeutic Antibodies
- Immunogenicity
- Glycans
- Immunity
- PET Imaging
- Two-pore Channels
- Purinergic Signalling
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 19 words, with their numbers
- Monoclonal Antibodies242 topics
- Cancer Immunotherapy222 topics
- Glycosylation222 topics
- CAR T Cells191 topic
- Chimeric Antigen Receptor191 topic
- Fc Receptors181 topic
- Therapeutic Antibodies181 topic
- Biosimilars61 topic
- Immunogenicity61 topic
- Cancer41 topic
- Glycans41 topic
- Dendritic Cells31 topic
- Immunity31 topic
- Lysosomal Calcium Signaling31 topic
- PET Imaging31 topic
- Radiopharmaceuticals31 topic
- Two-pore Channels31 topic
- Adenosine Receptors21 topic
- Purinergic Signalling21 topic
Where does Kevin H. Dang work?
Kevin H. Dang's main affiliation in the publication record is Tenneco (United States), United States.
How many publications and citations does Kevin H. Dang have?
OpenAlex counts 33 works and 765 citations for Kevin H. Dang, an h-index of 9, ranking #1,807,608 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Kevin H. Dang. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.